PortfoliosLab logoPortfoliosLab logo
ISIN
US4161962026
CUSIP
416196202
IPO Date
Nov 4, 1993

Highlights

Market Cap
$17.87M
Enterprise Value
$39.31M
EPS (TTM)
-$0.14
Total Revenue (TTM)
$155.27M
Gross Profit (TTM)
$55.70M
EBITDA (TTM)
$4.29M
Year Range
$2.22 - $4.48
ROA (TTM)
-1.16%
ROE (TTM)
-5.21%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Harte-Hanks, Inc. Common Stock

Often compared with HHS:
HHS vs. SCHGHHS vs. TRIN

Performance

HHS Performance Chart

Harte-Hanks, Inc. Common Stock (HHS) is down 19.9% since the beginning of the year. At $2 per share, HHS is trading 46.2% below its 52-week high of $4. Investors who bought $1,000 worth of HHS shares 5 years ago would now be looking at an investment worth $374.


Loading charts...

S&P 500 Index

Returns By Period

Harte-Hanks, Inc. Common Stock (HHS) has returned -19.93% so far this year and -37.08% over the past 12 months. Over the last ten years, HHS has returned -16.98% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Harte-Hanks, Inc. Common Stock

1D
0.42%
1M
-8.02%
YTD
-19.93%
6M
-27.84%
1Y
-37.08%
3Y*
-24.23%
5Y*
-17.87%
10Y*
-16.98%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HHS Monthly Returns History

Based on dividend-adjusted daily data since Nov 4, 1993, HHS's average daily return is +0.02%, while the average monthly return is +0.22%. At this rate, an investment would double in approximately 26.3 years.

Historically, 51% of months were positive and 49% were negative. The best month was Jun 2016 with a return of +60.8%, while the worst month was Mar 2020 at -47.3%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 7 months.

On a daily basis, HHS closed higher 46% of trading days. The best single day was Jun 10, 2016 with a return of +58.4%, while the worst single day was Jul 14, 2020 at -32.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.66%-9.25%-17.44%21.98%-9.71%-3.60%-19.93%
20254.66%-5.19%-6.07%4.17%-9.00%-12.53%-14.32%5.57%3.06%-16.17%21.23%-20.16%-41.55%
202413.99%-0.65%-2.73%-5.21%3.39%10.78%3.94%-10.78%-1.20%-4.44%-17.86%-11.82%-24.15%
20236.67%-14.84%-11.39%-10.31%-33.53%-2.32%4.93%12.35%0.77%0.31%4.29%-0.29%-41.92%
2022-12.37%-1.80%15.75%-2.77%23.10%40.62%2.04%17.69%-27.12%2.87%-12.47%16.43%53.82%
20213.82%22.59%24.29%19.77%26.68%-12.12%8.62%4.76%18.18%-7.05%11.81%-6.25%176.36%

Benchmark Metrics

Harte-Hanks, Inc. Common Stock has an annualized alpha of -3.97%, beta of 0.80, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since November 04, 1993.

  • This stock participated in 96.12% of S&P 500 Index downside but only 30.04% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-3.97%
Beta
0.80
0.10
Upside Capture
30.04%
Downside Capture
96.12%

Return for Risk

Risk / Return Rank

HHS ranks 11 for risk / return — in the bottom 11% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


HHS Risk / Return Rank: 1111
Overall Rank
HHS Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
HHS Sortino Ratio Rank: 1414
Sortino Ratio Rank
HHS Omega Ratio Rank: 1414
Omega Ratio Rank
HHS Calmar Ratio Rank: 88
Calmar Ratio Rank
HHS Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Harte-Hanks, Inc. Common Stock (HHS) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HHSBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.73

Sortino ratioReturn per unit of downside risk

-3.64

Omega ratioGain probability vs. loss probability

0.89

1.37

-0.48

Calmar ratioReturn relative to maximum drawdown

-0.87

2.78

-3.65

Martin ratioReturn relative to average drawdown

-1.54

12.44

-13.97

Dividends

Dividend History

Harte-Hanks, Inc. Common Stock provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%2.00%4.00%6.00%8.00%10.00%$0.00$0.50$1.00$1.50$2.00$2.50$3.00$3.5020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.85$3.40

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.63%10.49%

Monthly Dividends

The table displays the monthly dividend distributions for Harte-Hanks, Inc. Common Stock. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Harte-Hanks, Inc. Common Stock. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Harte-Hanks, Inc. Common Stock was 99.44%, occurring on Apr 2, 2020. The portfolio has not yet recovered.

The current Harte-Hanks, Inc. Common Stock drawdown is 98.86%.


Related event

Drawdown

Fall

Recovery

Underwater

COVID crash2020
-99.44%Apr 2020
14y 9mo
21y 7dJun 2005 - now
1999 bear market1999
-31.85%Nov 1999
7mo 21d2y 2mo
2y 10moMar 1999 - Jan 2002
1998 bear market1998
-29.53%Oct 1998
2mo 18d1mo 12d
4moJul 1998 - Nov 1998
Dot-com crash2000–2002
-27.36%Jul 2002
2mo 6d1y 5mo
1y 7moMay 2002 - Dec 2003
1994 correction1994
-16.47%Dec 1994
10mo 14d4mo 7d
1y 2moFeb 1994 - Apr 1995

Drawdown Indicators


HHSBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.44%

-56.78%

-42.66%

Max Drawdown (1Y)

Largest decline over 1 year

-42.96%

-9.10%

-33.86%

Max Drawdown (3Y)

Largest decline over 3 years

-74.18%

-18.90%

-55.28%

Max Drawdown (5Y)

Largest decline over 5 years

-87.14%

-25.43%

-61.71%

Max Drawdown (10Y)

Largest decline over 10 years

-93.94%

-33.92%

-60.02%

Current Drawdown

Current decline from peak

-98.86%

-1.80%

-97.06%

Average Drawdown

Average peak-to-trough decline

-51.58%

-10.71%

-40.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.18%

2.03%

+22.15%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Harte-Hanks, Inc. Common Stock over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Harte-Hanks, Inc. Common Stock is priced in the market compared to other companies in the undefined industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HHS relative to other companies in the undefined industry. Currently, HHS has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HHS in comparison with other companies in the undefined industry. Currently, HHS has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HHS

Add Harte-Hanks, Inc. Common Stock to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HHS